What is CSPC Pharmaceutical Group Operating Cash Flow per Share?
CSPC Pharmaceutical Group's operating cash flow per share for the
three
months ended in Dec. 2023 was $0.00.
CSPC Pharmaceutical Group's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of CSPC Pharmaceutical Group was -46.20% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -16.80% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 6.30% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 19.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for CSPC Pharmaceutical Group's Operating Cash Flow per Share or its related term are showing as below:
CHJTF'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -59.5 Med: 21.4 Max: 100.9
Current: -16.8
During the past 13 years, CSPC Pharmaceutical Group's highest 3-Year average Operating Cash Flow per Share Growth Rate was 100.90% per year. The lowest was -59.50% per year. And the median was 21.40% per year.
CHJTF's 3-Year OCF Growth Rate is ranked worse than 78.54% of 806
companies
in the Drug Manufacturers industry
Industry Median: 6.9
vs CHJTF: -16.80
CSPC Pharmaceutical Group Operating Cash Flow per Share Historical Data
The historical data trend for CSPC Pharmaceutical Group's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
CSPC Pharmaceutical Group Operating Cash Flow per Share Chart
Competitive Comparison of CSPC Pharmaceutical Group's Operating Cash Flow per Share
For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CSPC Pharmaceutical Group's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where CSPC Pharmaceutical Group's Price-to-Operating-Cash-Flow falls into.
CSPC Pharmaceutical Group Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
CSPC Pharmaceutical Group's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CSPC Pharmaceutical Group Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
CSPC Pharmaceutical Group (CSPC Pharmaceutical Group) Business Description
CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.
CSPC Pharmaceutical Group (CSPC Pharmaceutical Group) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CHJTF has been successfully added to your 